No Data
No Data
Longshen Rongfa (300534.SZ) announced first-quarter results, net profit of 22.141 million yuan, an increase of 10.68%
Longshen Rongfa (300534.SZ) released its report for the first quarter of 2024. The company's revenue was 2.55...
Longshen Rongfa (300534.SZ): As of April 10, 2024, the number of shareholders of the company was 31,541
Gelonghui April 12 | Longshen Rongfa (300534.SZ) said on the investor interactive platform that according to data provided by China Securities Registration and Settlement Co., Ltd., the number of shareholders of the company as of April 10, 2024 was 31,541.
Longshen Rongfa (300534.SZ) was commissioned to prepare in-hospital preparations for breast disease relief tablets and psoriasis tablets from the Second Hospital of Lan University
Longshen Rongfa (300534.SZ) issued an announcement. Recently, the company received the Second Hospital of Lanzhou University (“Second Hospital of Lan University...
Express News | Longshen Rongfa: Received a certificate for the preparation of traditional Chinese medicine formulations commissioned by a medical institution
Longshen Rongfa (300534.SZ): As of March 29, 2024, the number of shareholders of the company was 31,929
Gelonghui, April 1 | Longshen Rongfa (300534.SZ) said on the investor interactive platform that according to data provided by China Securities Registration and Settlement Co., Ltd., the number of shareholders of the company as of March 29, 2024 was 31,929.
Longshen Rongfa (300534.SZ): The Shenzhen Stock Exchange terminated the review of the company's application for a fixed share increase
Zhitong Finance App News, Longshen Rongfa (300534.SZ) announced that on March 21, 2024, the company and sponsor Guotai Junan Securities Co., Ltd. submitted “Gansu Longshen Rongfa Pharmaceutical Co., Ltd.'s Application to Withdraw the Application Documents for Issuance of Shares to Specific Targets” and “Application by Guotai Junan Securities Co., Ltd. to withdraw the application documents issued by Gansu Longshen Rongfa Pharmaceutical Co., Ltd. to specific targets”. Recently, the company received the “On Termination of Gansu Longshen Rongfa Pharmaceutical Co., Ltd.” issued by the Shenzhen Stock Exchange
No Data